ArticleInternational journal of molecular sciences2019
The
Open access · goldAbstract read
In one paragraph
Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 21 citations in OpenAlex.
- CXCR4-modification enhances CAR-T efficacy by improving tumor tracking and bone marrow homing in B-cell malignancies.Signal transduction and targeted therapy · 2026Article
- The Role of Chemokine-Related Genes in Diffuse Large B-Cell Lymphoma Prognosis and Tumor Microenvironment Characteristics.Analytical cellular pathology (Amsterdam) · 2026Article
- HIV infection complicated with talaromyces marneffei, tuberculosis, hemophagocytic lymphohistiocytosis and non-Hodgkin lymphoma: a complex case report.BMC infectious diseases · 2025Article
- Study on the regulation of Treg cell infiltration by EZH2 through CXCR4/CXCL12 in diffuse large B-cell lymphoma.Clinical and experimental medicine · 2025Article
- Chemokine Receptor Profiles as Predictors of Survival and Early Progression in Follicular Lymphoma.EJHaem · 2025Article
- Review
- CXCR4 Inhibition Enhances the Efficacy of CD19 Monoclonal Antibody-Mediated Extermination of B-Cell Lymphoma.International journal of molecular sciences · 2025Article
- The malignant dialogue between cancer-associated fibroblasts and osteosarcoma cells: microenvironment-mediated drug resistance and therapeutic targets.Frontiers in immunology · 2025Review
- Therapeutic Perspectives of HIV-Associated Chemokine Receptor (CCR5 and CXCR4) Antagonists in Carcinomas.International journal of molecular sciences · 2022Review
- Distinct Chemokine Receptor Expression Profiles in De Novo DLBCL, Transformed Follicular Lymphoma, Richter's Trans-Formed DLBCL and Germinal Center B-Cells.International journal of molecular sciences · 2022Article
- Altered pathways and targeted therapy in double hit lymphoma.Journal of hematology & oncology · 2022Review
- GPCR Inhibition in Treating Lymphoma.ACS medicinal chemistry letters · 2022Article
- Specific Cytotoxic Effect of an Auristatin Nanoconjugate Towards CXCR4International journal of nanomedicine · 2021Article
- Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B-cell lymphoma.Clinical and translational medicine · 2020Article
- The Importance of Tumor-Host Interactions in Adult B-Cell Leukemias and Lymphomas.International journal of molecular sciences · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors at 2 institutions in 1 country.
Katrin PansyDivision of Hematology, Medical University Graz; Auenbruggerplatz 38, 8036 Graz, Austria. katrin.pansy@medunigraz.at.ORCID 0000-0001-6972-4937
Julia FeichtingerDivision of Cell Biology, Histology and Embryology, Gottfried Schatz Research Center for Cell Signaling, Metabolism and Aging, Medical University of Graz, Neue Stiftingtalstraße 6/II, 8010 Graz, Austria. julia.feichtinger@medunigraz.at.
Barbara EhallDivision of Hematology, Medical University Graz; Auenbruggerplatz 38, 8036 Graz, Austria. barbara.ehall@medunigraz.at.
Barbara UhlDivision of Hematology, Medical University Graz; Auenbruggerplatz 38, 8036 Graz, Austria. barbara.uhl@medunigraz.at.ORCID 0000-0002-8460-8771
Miriam SedejOtto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Division of Pharmacology, Medical University of Graz, Universitätsplatz 4/I, 8010 Graz, Austria. miriam.sedej@medunigraz.at.
David RoulaOtto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Division of Pharmacology, Medical University of Graz, Universitätsplatz 4/I, 8010 Graz, Austria. david.roula@medunigraz.at.ORCID 0000-0003-0472-6784
Beata PurscheDivision of Hematology, Medical University Graz; Auenbruggerplatz 38, 8036 Graz, Austria. Beata_Prusche@yahoo.de.
Axel WolfDivision of General Otorhinolaryngology, Medical University of Graz, Auenbruggerplatz 26, 8036 Graz, Austria. axel.wolf@klinikum-graz.at.
Manuel ZoidlInstitute of Organic Chemistry, Graz University of Technology, Stremayrgasse 9/4, 8010 Graz, Austria. manuel.zoidl@tugraz.at.
Elisabeth SteinbauerDiagnostic & Research Institute of Pathology, Medical University Graz, Neue Stiftingtalstraße 6, 8010 Graz, Austria. elisabeth.steinbauer@klinikum-graz.at.
Verena GruberDiagnostic & Research Institute of Pathology, Medical University Graz, Neue Stiftingtalstraße 6, 8010 Graz, Austria. verena.gruber@klinikum-graz.at.
Hildegard T GreinixDivision of Hematology, Medical University Graz; Auenbruggerplatz 38, 8036 Graz, Austria. hildegard.greinix@medunigraz.at.
Katharina T ProchazkaDivision of Hematology, Medical University Graz; Auenbruggerplatz 38, 8036 Graz, Austria. KatharinaTheresa.Prochazka@klinikum-graz.at.
Gerhard G ThallingerInstitute of Computational Biotechnology, Graz University of Technology, Petersgasse 14/V, 8010 Graz, Austria. gerhard.thallinger@tugraz.at.ORCID 0000-0002-2864-5404
Akos HeinemannOtto Loewi Research Center for Vascular Biology, Immunology and Inflammation, Division of Pharmacology, Medical University of Graz, Universitätsplatz 4/I, 8010 Graz, Austria. akos.heinemann@medunigraz.at.ORCID 0000-0002-8554-2372
Christine Beham-SchmidDiagnostic & Research Institute of Pathology, Medical University Graz, Neue Stiftingtalstraße 6, 8010 Graz, Austria. christine.beham@medunigraz.at.
Peter NeumeisterDivision of Hematology, Medical University Graz; Auenbruggerplatz 38, 8036 Graz, Austria. peter.neumeister@medunigraz.at.
Tanja M WrodniggInstitute of Organic Chemistry, Graz University of Technology, Stremayrgasse 9/4, 8010 Graz, Austria. t.wrodnigg@tugraz.at.
Karoline FechterDivision of Hematology, Medical University Graz; Auenbruggerplatz 38, 8036 Graz, Austria. fechterkaroline@gmail.com.
Alexander Ja DeutschDivision of Hematology, Medical University Graz; Auenbruggerplatz 38, 8036 Graz, Austria. alexander.deutsch@medunigraz.at.ORCID 0000-0003-0914-2809
Medical University of Graz · ATGraz University of Technology · AT
Funding
Austrian Science Fund FWF T 923
Abstract
In tumor cells of more than 20 different cancer types, the
Indexed as
AminoquinolinesAntineoplastic AgentsApoptosisBenzimidazolesBiomarkersButylaminesCell Line, TumorCell MovementCell ProliferationChemokine CXCL12ExonsFemaleGene ExpressionHeterocyclic Compounds, 1-RingHumansLymphoma, Large B-Cell, DiffuseAminoquinolinesAntineoplastic AgentsBenzimidazolesBiomarkersButylaminesChemokine CXCL12CXCL12 protein, humanCXCR4 protein, humanHeterocyclic Compounds, 1-RingmavorixaforReceptors, CXCR4CXCR4 antagonist 3CXCR4-CXCL12-axis 2DLBCL 1
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.